SAM
PPH icon

Synergy Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Synergy Asset Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,583
Closed -$1.96M – 169
2023
Q3 		$1.96M Buy
+24,583
New +$1.98M 0.39% 62

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Synergy Asset Management's PPH Position: Q4 2023 in Review

Synergy Asset Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2023, closing a stake of 24,583 shares — an estimated $1.96M sold.

Synergy Asset Management first reported a position in PPH in Q3 2023 and held it in 1 quarter. The position peaked at $1.96M in Q3 2023. 110 funds tracked by Wall St. Rank hold PPH as of Q4 2023.

  • Synergy Asset Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2023 after selling out during the quarter.
  • Synergy Asset Management sold 24,583 VanEck Pharmaceutical ETF shares in Q4 2023, an estimated $1.96M.
  • Synergy Asset Management first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and held it in 1 quarter.
  • Synergy Asset Management's VanEck Pharmaceutical ETF position peaked at $1.96M in Q3 2023.
  • 110 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2023.

Based on Synergy Asset Management's 13F filing for Q4 2023, filed 19 Jan 2024.